Form 4 for DXR DAXOR CORP
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001493152-25-023651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 2025-11-12 | DXR | Jefferies John | Chief Medical Off | P - Purchase | $0.00 | +2,344 | 17.6K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Daxor Common Stock | 2025-11-12 | P | A | 2,344 | $0.00 | 17,616 | D | — | — | (F1) 2,344 shares granted vest on November 12, 2025. |